<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Functional <z:mpath ids='MPATH_366'>neuroendocrine tumors</z:mpath> are often low-grade malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> that can be cured by surgery if detected early, and such detection may in turn be accelerated by the recognition of neuropeptide hypersecretion syndromes </plain></SENT>
<SENT sid="1" pm="."><plain>Uniquely, however, relief of peptic symptoms induced by hypergastrinemia is now available from acid-suppressive drugs such as <z:chebi fb="0" ids="49200">proton-pump inhibitors</z:chebi> (<z:chebi fb="4" ids="53266">PPIs</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>Here we describe a clinical case in which time to diagnosis from the <z:hpo ids='HP_0003674'>onset</z:hpo> of peptic symptoms was delayed more than 10 years, in part reflecting symptom masking by continuous prescription of the <z:chebi fb="4" ids="53266">PPI</z:chebi> <z:chebi fb="14" ids="7772">omeprazole</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>We propose diagnostic criteria for this under-recognized new clinical syndrome, and recommend that physicians routinely measure serum gastrin levels in persistent cases of <z:chebi fb="4" ids="53266">PPI</z:chebi>-dependent <z:e sem="disease" ids="C0013395" disease_type="Disease or Syndrome" abbrv="">dyspepsia</z:e> unassociated with H. pylori </plain></SENT>
</text></document>